Literature DB >> 9301561

Persistence of hepatic hepatitis B virus after serological clearance of HBsAg with autologous peripheral stem cell transplantation.

G K Lau1, P C Wu, R Liang, S T Yuen, W L Lim.   

Abstract

Delayed clearance of hepatitis B surface antigen was previously reported in a 38 year old woman after high dose chemotherapy with autologous peripheral blood stem cell rescue. Sixteen months later, this patient remained hepatitis B surface antigen negative, hepatitis B surface antibody positive, and serum hepatitis B DNA negative by polymerase chain reaction. Serial liver biopsies (one at hepatitis B e antigen positive stage, one at hepatitis B e antibody positive stage, and one at hepatitis B surface antigen negative and hepatitis B surface antibody positive stage) showed a gradual resolution of the inflammatory activity with loss of hepatitis B e antigen and then hepatitis B surface antigen in the serum. However, the degree of fibrosis, though mild, remained the same. With the serological clearance of hepatitis B surface antigen, a small amount of hepatitis B virus DNA was still detectable in the nuclei of liver cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9301561      PMCID: PMC500132          DOI: 10.1136/jcp.50.8.706

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.

Authors:  G K Lau; A S Lok; R H Liang; C L Lai; E K Chiu; Y L Lau; S K Lam
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

2.  Loss of HBsAg in chronic hepatitis B carrier following high-dose chemotherapy and autologous peripheral blood stem cell rescue for lymphoma.

Authors:  G K Lau; R Liang; E K Chiu; C K Lee; S K Lam
Journal:  Am J Hematol       Date:  1995-12       Impact factor: 10.047

3.  Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B.

Authors:  T L Fong; A M Di Bisceglie; M A Gerber; J G Waggoner; J H Hoofnagle
Journal:  Hepatology       Date:  1993-12       Impact factor: 17.425

Review 4.  Natural history and control of perinatally acquired hepatitis B virus infection.

Authors:  A S Lok
Journal:  Dig Dis       Date:  1992       Impact factor: 2.404

5.  Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen.

Authors:  J H Hoofnagle; L B Seeff; Z B Bales; H J Zimmerman
Journal:  N Engl J Med       Date:  1978-06-22       Impact factor: 91.245

6.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

Authors:  B Rehermann; C Ferrari; C Pasquinelli; F V Chisari
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

7.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

Authors:  A S Lok; R H Liang; E K Chiu; K L Wong; T K Chan; D Todd
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

8.  Detection of hepatitis B virus DNA in paraffin-embedded liver tissues in chronic hepatitis B or non-A, non-B, hepatitis using the polymerase chain reaction.

Authors:  M Shindo; T Okuno; K Arai; M Matsumoto; M Takeda; K Kashima; M Shimada; Y Fujiwara; Y Sokawa
Journal:  Hepatology       Date:  1991-01       Impact factor: 17.425

9.  Hepatic expression of hepatitis B virus genome in chronic hepatitis B virus infection.

Authors:  P C Wu; J W Fang; C L Lai; S S Lau; C K Lo; A Lai; J Y Lau
Journal:  Am J Clin Pathol       Date:  1996-01       Impact factor: 2.493

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

  10 in total
  2 in total

1.  Prevalence of occult HBV infection in haemodialysis patients with chronic HCV.

Authors:  Vedat Goral; Hamza Ozkul; Selahattin Tekes; Dede Sit; Ali Kemal Kadiroglu
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

2.  Prevention and treatment of hepatitis virus infections in hematopoietic stem cell transplant recipients.

Authors:  Suparno Chakrabarti; Somnath Mukherjee
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-10       Impact factor: 2.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.